Open Insider Trading Activity for Opiant Pharmaceuticals, Inc. Chief Development Officer Ellison Mark Jason Heath
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OPNT | 2023-01-31 | 2023-01-27 | Opiant Pharmaceuticals, Inc. | Ellison Mark Jason Heath | Chief Development Officer | Sell | 1 | 610 | $20.26 | $12,358.60 | 3.15% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting OPNT | 2023-01-05 | 2023-01-05 | Opiant Pharmaceuticals, Inc. | Ellison Mark Jason Heath | Chief Development Officer | Sell | 1 | 1,806 | $20.20 | $36,481.20 | 8.35% | View Filing |